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other viruses.

This fall, the Utah Agricultural Experiment Station and USU’s College of

Agriculture and Applied Sciences hosts an international conference that will

bring together experts in large animal genetic engineering. These specialized
animal models are important in work that may improve livestock production
breathe freely, or lead to treatments for neurological damage.

Our faculty are also organizing a second Utah One Health Symposium

to focus on the interrelationships of animal health, human health and the

environment. Understanding human, environmental and animal health are

and students do on research farms and in labs and classrooms, all aimed at
improving lives.

Ken White
Director, Utah Agricultural Experiment Station
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WHAT’S ON YOUR PLATE?
UAES Researcher
Examines Connections
Between Diet and
Cancer Risk
By Shelby Ruud

S

mall, everyday decisions such
as what to put in your grocery
cart or which restaurant to eat
at may seem insignificant. But in reality, what’s on your plate and what’s
missing from your plate could have
more long-term health consequences
than previously thought. The Applied
Nutrition Research Group, a team of
researchers in Utah State University’s
College of Agricultural and Applied
Sciences with a diverse range of
expertise, is examining certain health
concerns and how they relate to diet.
Utah Agricultural Experiment Station
researcher and Utah State University
Associate Professor Abby Benninghoff and her team are specifically examining how the food we eat impacts
the rate and severity of colon cancer.
Scientists have long been inter-

ested in studying cancer. Ideally, they

would be able to use humans to study
the complexities of the disease, but
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unless researchers are willing and

able to study cancer patients for de-

cades at a time, it’s just not feasible for
diseases that typically develop later

in life. Instead, researchers use mice
as models for humans. “This is one
of the biggest challenges when we

use laboratory animals as surrogates
for people,” Benninghoff said. “We

all know a mouse is not a human. But
we can optimize our studies the best
that we can and make these models
better.”

Optimizing animal models to study

cancer risk is one aspect that makes

this project unique. “Historically, when
scientists have looked at cancer

in mice, they feed these animals a

healthy diet to get them to the optimal

level of health,” Benninghoff said. “My
colleagues and I looked at that prac-

tice and said, ‘Well, that really doesn’t

emulate what Americans eat.’” Instead

of following the traditional model, the
research team developed a diet for

rodents that more closely mimics what
the average American is eating: a diet

high in fats, high in simple sugars, and
lacking many vitamins and minerals.

After implementing the “Western

diet” into their studies, Benninghoff’s

team compared mice on a healthy diet
to mice consuming the diet that re-

flects what Americans eat. Mice on the
Western diet had a much higher rate
for tumor development in the colon,

which didn’t surprise Benninghoff and
her colleagues. Their findings fit with
other epidemiological research that

points to poor diet being a huge risk

factor for colon cancer. The next step
for the research team is to figure out
why this is the case.

The team is examining the gut

microbiome, which is the collection of
microorganisms in our stomachs. The

Utah State University Associate Professor and Utah Agricultural Experiment Station researcher Abby Benninghoff.

human gut is host to an ecosystem of more than 100 trillion
bacteria. This microbiome plays a big role in the body’s

digestive system—it metabolizes indigestible compounds, it

produces energy and it provides defense against pathogens.
With the gut microbiome playing all these roles, it’s possible that protection against colon cancer may be dictated
in part by the gut microbiota population. In fact, the gut

microbiomes of patients with gut inflammation are noticeably
different from healthy ones, with consistent observations

of less diversity and richness of the microbial community.
Understanding specific gut microbiome patterns that are

associated with disease risk could provide new targets for
risk reduction or therapy.

The role of micronutrients has also been a point of

interest for the research team. Benninghoff said many people
think of poor food choices and associate them with macronu-

trients like fats. Benninghoff’s work suggests that a lack of micronutrients, including vitamins and minerals, plays a much

more substantial role in cell health and increased cancer risk.
“The role of micronutrients was a bit of a surprise, based

on what we’d previously thought,” Benninghoff said. “But

when you look at how these micronutrients have a central role
in maintaining proper cell functions, it’s not really a surprise

at all.” Benninghoff’s team is now working on understanding

which micronutrients play a key role in the long-term health of
the intestine.

It’s not all bad news, however. Instead of focusing solely

on factors that exacerbate diseases, the research team is

also interested in foods that do the opposite and reduce the
risk of cancer. Bioactives are chemicals naturally found in

certain foods, but they’re not the standard vitamins and minerals. These chemicals can interact with our cells and pro-

mote health, prevent inflammation and block some pathways
that might lead to cancer. The Applied Nutrition Research

Group is studying bioactives in foods such as broccoli, green
tea, tart cherries—even purple corn.
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“The best advice I can
AWARD WINNING

give for anyone who wants

In 2015 and again in

to reduce their cancer

2016, Benninghoff and her
collaborators, including USU

risk and improve their

toxicologist, Professor Roger
Coulombe, won the Multi-

overall health is to make

State Research Award from
the Western Association

their plate as colorful as

of Agricultural Experiment
Station Directors.This award

possible,” Benninghoff

recognizes excellence within
a collaboration that includes

said. “A lot of foods that

representatives from several
states across the nation.

have the healthy bioactives

“The work that [these]
researchers have conducted

are brightly colored, so

has increased our under-

look for the vibrant greens,

standing of the complex
relationship between bio-

blues and reds.”

active dietary chemicals
and human health, which
is of paramount concern
to consumers, agricultural
producers, food processors,
health professionals, and
policymakers charged with
maintaining a safe and nutritious food supply.”
The team includes researchers from 18 other
universities and government
research agencies.

And the benefits of a colorful plate could have implications far into the future.

Using the mouse models for their research, the team is examining ancestral exposure to diet. They are interested in whether or not someone’s poor food choices

could negatively affect the health of their offspring generations into the future. This
field of research is called epigenetic inheritance and examines the epigenome,

which is another layer of genetic code similar to the genome, and how it can be

inherited across generations. The research team believes that this could be a key
to understanding cancer risk.

“People are already recommended to eat well,” Benninghoff said. “If we tell

people that your children, or your grandchildren, or your great-grandchildren

could suffer because of your diet choices, I think it could lend weight to the nutrition recommendations that doctors give their patients.”

Benninghoff and other team members, including USU researchers Korry

Contact Info:
Abby Benninghoff
Abby.Benninghoff@usu.edu

Hintze, Michael Lefevre, Robert Ward and Jeffery Broadbent and graduate

student Sumira Phatak, are several years into this project and are beginning to

accumulate the results of their various studies. Benninghoff said one of the most
rewarding parts has been tabulating the data, examining the results and asking
“What did we learn?”. The team is always considering where they can take this
project next.

“When I was a graduate student, my biggest fear was that I’d run out of

ideas,” Benninghoff said. “But it’s been the complete opposite. There’s so much I
want to do in terms of research. The ideas are absolutely not in short supply.” ¤
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UNCOMMON

HAMSTERS
HELPING

FIGHT
COMMON
VIRUSES
By Nancy Solomon & Lynnette Harris
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can become very dangerous, such as for a child who is

undergoing a bone marrow transplant to treat leukemia.”

Wold and his colleagues found that Type 1 interferon

is critical to preventing adenovirus from multiplying.

Interferon is a protein and part of the body’s immune

response that fights against invading pathogens. Cells
that are infected by a virus release interferon to signal
nearby non-infected cells to be on alert to fight the
invading virus.

Researchers led by Zhongde Wang, associate

professor of veterinary diagnostics and infectious

diseases in USU’s Department of Animal, Dairy and

Veterinary Sciences and co-senior author of the paper,

turned off the STAT2 gene in a group of Syrian hamsters,
which disrupted the Type 1 interferon pathway by

interrupting the cascade of cell signaling. The team

compared that group with a group of wild-type control

animals, both of which had adenovirus. The genetically
modified Syrian hamsters had 100 to 1,000 times more
virus in their bodies than the control.

“While thousands of papers have been published on

the replication of adenovirus in a cell culture model, until

now, not much has been understood about the molecular
details during adenovirus replication in humans,” Wold
said.

U

sing an animal model they developed, Utah
State University and Saint Louis University
researchers have identified a strategy that could
keep a common group of viruses called adenoviruses
from replicating and causing sickness in humans.
The study, published in the Aug. 20 issue of PLOS

Pathogens, is the first to report use of a genetically

modified Syrian hamster that may prove important in
studying other dangerous viruses.

“The adenovirus can cause colds and infections in

the eyes and respiratory system and generally are not

serious,” said William Wold, co-senior author of the paper
and chair of molecular microbiology and immunology at

Saint Louis University. “However, like many other viruses,
adenovirus can replicate at will when a patient’s
immune system is suppressed. Adenovirus
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Wang said, “Besides providing an insight into

adenovirus infection in humans, our results are also

interesting from the perspective of the animal model: the

STAT2 knockout Syrian hamster may also be an important
animal model for studying other viral infections, including
Ebola, hanta and dengue viruses.”

The animals used in the study with the STAT2 gene

disrupted – or knocked out – are the first Syrian
hamsters developed for gene-targeting.

“Due to their unique physiology, the

Syrian hamster offers advantages over

other rodent species in modeling human

diseases,” Wang said. “But the application
of hamsters as animal models suffered

from the lack of genetic tools to engineer

their genomes. The success we achieved

with gene-targeting in the Syrian hamster provides the

opportunity to create genetically engineered hamsters
as models for many of the human diseases for which

there are either no existing animal models or models with
severe limitations.”

Previously, Wold led a research team that identified

the Syrian hamster as an appropriate animal model
to study adenoviruses because human adenovirus

replicates in these animals, causing sickness that is
similar to that seen in humans. Wang said the work
reported in PLOS

engineered hamsters, in collaboration with Kong’s

group in South Korea. The initial advancement was also
supported by technical contributions from two other

laboratories at USU led by Ken White, animal scientist
and dean of the College of Agriculture and Applied

Sciences, and Thomas Bunch, emeritus professor of
animal science.

The paper is available on the PLOS Pathology

website at: http://journals.plos.org/plospathogens/
article?id=10.1371/journal.ppat.1005084 ¤

Pathogens is significant
because there was

previously no animal
model for studying

adenovirus replication
without using drugs

to suppress animals’

immune systems. The

study provides a basis
for using the STAT2

Knockout hamsters to
understand infection

and to develop antiviral
drugs and vaccines.
In addition,

Wang said, a variety
of adenoviruses –

known as oncolytic
adenoviruses –

preferentially infect
and kill tumor cells

are of great interest
in treating human

cancers, but none

of the small animal

models currently in use
allows adenoviruses

to replicate effectively.
Because the newly

developed hamsters do permit the virus to replicate, they
open a door to new methods of developing and studying
cancer-fighting adenoviruses.

Other members of the research team include Karoly

Top Left: Associate Professor Zhongde Wang.
Bottom Left: Schematic of adenovirus: National Institutes of
Health.
Above: Transmission electron micrograph (TEM) of adenovirus
virions. Photo courtesy of CDC/ Dr. G. William Gary, Jr.

Toth, Baoling Ying, John E. Sagartz, Jacqueline F.

Spencer and Ann E. Tollefson, Saint Louis University;

Contact Info:

Il-Keun Kong, Gyeongsang National University, Jinju,

Zhongde Wang
Zonda.Wang@usu.edu

Sang R. Lee and Wang, Utah State University; and
South Korea.

Wang’s research group made a technical

breakthrough in 2013 with gene targeting in the golden

Syrian hamster and produced the world’s first genetically
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Science
vs.
Viruses
By Lynnette Harris

W

hen viruses cause disease and make local,
national and international news, most of us react
with some anxiety, take precautions to prevent or
limit contact with the virus and adopt a heightened awareness of symptoms. When Professor John Morrey and his
colleagues at Utah State University’s Institute for Antiviral
Research hear and read stories of dangerous emerging or
recurring diseases, it’s rarely “news” to them, but it brings a
renewed urgency to their work.
“When people ask ‘How’s your work going?’ I tend to

always look ahead and think of the challenges and needs

instead of looking back and seeing our successes, and we’ve
had some great successes,” Morrey, the institute’s director,
said. “There is always more to do. We always need more

data, more ideas, and there are always more grants to write,
more papers to write, more things to understand.”

Morrey can be forgiven for focusing on the challenges.

When your work is studying viruses, you may experience
some exciting breakthroughs, but you are never really
finished.

The institute’s team includes seven lead investigators

who are Department of Animal, Dairy and Veterinary Sciences
faculty members, six PhD-level senior research associates,
and several full-time and student technicians. The viruses
and diseases they study—think influenza, hanta, dengue,

West Nile, chikungunya, SARS and Zika—could comprise an
international “Most Not Wanted” list. The researchers don’t
discover new drugs, they test possible treatments in cell

culture and animal models, investigate basic mechanisms of

8 Utah Science

how viruses function and cause disease and search for ways
to disrupt a viruses’ particular ability to do damage.

Doing basic biological research is important, but not filled

with daily, flashy “Eureka” moments. However, without basic
research the development of drugs, vaccines and tests for

diseases would never happen. For example, the researchers’
discovery of the ways in which viruses like West Nile infect

the brain stem and cause respiratory problems is important

because it gives drug developers better targets for treatments
and vaccines. Morrey likened it to being a guide.

“If you go fishing in a large lake you need to go where

the fish are,” he said. “By discovering that West Nile and

other neurological viruses can cause respiratory deficits,

particularly with lesions in the spinal cord and brain stem,

we’ve helped get scientists in the part of the lake where they
can be productive.”

The team reached a notable milestone this year,

surpassing $107 million in grants and contracts since the
institute was founded in 1977 and led by Robert Sidwell,

now an emeritus professor. But don’t go looking for them in

a gleaming, high-profile research center. Most of their work
goes on in secured laboratories with up-to-date equipment

and protocols, but the modest surroundings belie the caliber
of research that goes on there every day.

To Morrey, surpassing the $100 million mark in grant

funding represents the group’s collective work and “the many
pharmaceuticals in which we have played a part, and seeing
them used by people around the world to fight viral disease
and improve lives.”

VIRUSES IN THE LAB
Studying viruses in cell culture can tell scientists a great

deal, but animal models play crucial roles in understanding

viruses and testing possible treatments. Research Associate
Professor Justin Julander explained that the complexity

of the body, whether human, mouse or hamster, can’t be

replicated in a petri dish or flask. Experiments in cell culture
are important for targeting and measuring some responses,
but cultures don’t replicate nearly countless variables like

neuron function, respiration and immune response. Studies

in animal models are important steps on the path to treating
humans and running complex and expensive clinical trials
of vaccines and drugs in humans. However, mice and

hamsters are not naturally susceptible to virus strains that
infect humans.

Associate Research Professor Bart Tarbet pointed out

that a key reason the researchers can do their work is the

institute’s colony of mice with specific genes “knocked out”
to make them receptive to virus infection. Colleagues at

USU also recently developed a first-of-its-kind, genetically
engineered hamster that is proving valuable in the search

for Zika virus treatments. Tarbet’s lab works with genetically
engineered mice in the search for a new model for

EV-D68 cases. Most troubling though was that some people
developed a polio-like neurological disease, not just the

usual respiratory infection that causes problems primarily

for the very young,
the very old and

people with asthma.
With funding from

National Institutes of

Health (NIH), Tarbet’s
lab is focused on

developing a reliable
testing model, and

will follow that with 2
years of evaluating

possible treatments.
It’s important to

note that most drugs
don’t make the cut
Left: Colorized transmission electron micrograph of avian influenza A H5N1 viruses (seen in gold) grown in
MDCK cells (seen in green). Photo Credit: Cynthia Goldsmith, Centers for Disease Control and Prevention
Right: This photo shows an electron micrograph of a thin section of EV-D68, showing the numerous, spherical
viral particles. Image source: Cynthia S. Goldsmith and Yiting Zhang, CDC
Above: This is a transmission electron micrograph (TEM) of the West Nile virus (WNV). See PHIL 2290 for
a black and white version of this image. Photo Credit: Cynthia Goldsmith, Centers for Disease Control and
Prevention

treatments of enterovirus D68 (EV-D68). The virus is one

from cell culture

to tests in animal

models and even

fewer progress to
clinical trials.

“For example,

3 years ago the

institute screened

among a family that includes polio and more than a 100

over 10,000 drugs to treat influenza in cell culture,” Tarbet

for Disease Control and Prevention has tracked since 1987.

the virus and just those few were considered for testing in

non-polio viruses, and has caused illness that the Centers

said. “Of those, fewer than 2 percent showed activity against

But in 2014, there was a spike in the number and severity of

animal models.”
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Julander said

because it costs

millions of dollars
to develop a new

drug and bring it to

market, the institute’s
team feels fortunate
to be doing work
at the university

where they are not

tied to a company’s
bottom line. Morrey
added that some

people believe that
any scientist who

associates with the
pharmaceutical

industry has been
bought off.

“The fact is, the

data we generate

is completely unbiased, and whether it’s good news or

bad news for a particular treatment, they get whatever we
learn,” Morrey said.

CHALLENGES: PAST AND PRESENT
Battling established and emerging virus diseases is

a complicated task for many reasons, some due to the

nature of the viruses themselves and some because of
the actions of people and animals they affect.

“One of the things that makes viral infections so

difficult to treat is that viruses rely on the host’s cells

for growth,” Morrey said. “It is the biggest challenge in

developing therapies. Viruses rely on the machinery of
the cells they infect. That is not the case with bacterial

infections because, with a couple of exceptions, bacteria
live outside our cells. So some of the conceivable

approaches to eliminating a virus also eliminates the

host’s cell. Virologists like to do better than that and find

very specific, unique viral processes that can be targeted
so the cell is not harmed, but the virus is eliminated.”
Another vexing characteristic of viruses is their

ability to mutate, adapting to new surroundings or drug
challenges. This ability allows viruses to expand their

ranges, cause infection in new ways and become less or
more virulent. It also means that once researchers have

characterized a virus and how it works, the virus may have

already changed. When viruses change in ways that make
them more virulent or easier to transmit, the results can be
devastating.

Such was the case with Spanish flu in 1918-1919.

10 Utah Science

Top: Model of H1N1 Influenza virus.
Above: The illustration shows a viral membrane decorated
with spike glycoproteins; highlighted in red is a potential
neutralization site, which is a protein sequence that might be
used as a target for vaccines to combat viruses such as MERSCoV and other coronaviruses. Photo Credit: David Veesler,
University of Washington
Right: The core of the USU’s Institute for Antiviral Research
are faculty members (left to right, front) Justin Julander, Dale
Barnard, Craig Day, (center) Don Smee, John Morrey (back)
Brian Gowan, Bart Tarbet.

That strain of influenza—a subtype of avian

influenza H1N1—became more deadly

and easier to spread, explained Research
Professor Dale Barnard. As a result,

20-40 million people died in a worldwide

pandemic, far more than the 17 million who
were killed in combat in that final year of
World War I.

“Sometimes research can be driven

by fear and media attention,” Barnard said.
“But the experience of Spanish flu is one
reason we are so vigilant and put great

effort into understanding newly emerging
viruses. We want to be able to intervene

before something like that happens again.”
Another public health challenge is

that people are very mobile today and

can transport viruses to new locales with
greater speed. Barnard said that prior to

the mid-20th century the geographic range
of two viruses he studies, Severe Acute

Respiratory Syndrome (SARS) and Middle

East Respiratory Syndrome (MERS), would
have been quite limited. But today planes

transport passengers and viruses between
countries and regions of the world in a
matter of hours.

Barnard and his team are at work

screening antiviral drugs for effectiveness
against MERS, coronavirus infections and
respiratory syncytial virus (RSV) among

other respiratory viruses. He observed that
there are tools for drug development and
testing that make the work faster than it

was at the start of his career, but drug discovery hasn’t accelerated as rapidly as viruses’ abilities to spread.

Changing climate presents another challenge. Many virus-caused diseases are zoonotic, meaning they arise

in animals and spread to humans. Mammals, birds and insects, like the now-famous, Zika-carrying Aedes aegypti

mosquito, act as vectors for spreading viruses. Their ranges may expand or at least change as the climate and their
habitats change.

ZIKA VIRUS IN THE NEWS
By the time stories about Zika virus hit mainstream media in the U.S. this spring, the Institute for Antiviral Research

had already been at work with the virus for several months with funding from the NIH. The team of researchers has

since demonstrated in mice and hamsters that the virus does transfer from mother to fetus and cause growth restriction
and other developmental anomalies at various times during fetal development. That gives the team good models for

studies, including evaluation of a possible vaccine and use of therapeutic antibodies that may stimulate the immune
system to attack the virus.

Julander, who leads the institute’s Zika virus research, said they have seen size differences and ocular deformities

in mouse pups born to dams that were infected with Zika virus. It appears that infection during the first trimester of
pregnancy is the most troubling.

“We previously found with West Nile virus that infection in the first trimester is the most critical time for abnormal
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fetal development and we see the same thing with

Zika,” Julander said. “We need a vaccine to protect
against Zika virus because more than 80 percent

of people who get the virus have no symptoms or

develop only a mild illness. The key to fighting most
viral infections is starting treatment when the viral
load is small. No one is going to go to the doctor

because they got a mosquito bite, so by the time

someone feels symptoms the virus has become well
established.”

Though both West Nile and Zika virus are

spread by mosquitoes and can cause neurological
disease, Morrey said there are key differences

between two. Zika virus can be spread from one

infected person to other people via mosquito bites.
It can also be sexually transmitted. West Nile does
not spread in those ways.

“Zika can mutate, and it does” Morrey said.

“It’s very interesting because you can get a blood

sample, but can’t culture it by some of the expected
cell culture techniques because its genes have

already changed in the time it took for viremia to
occur (the virus to develop in the bloodstream).
The viruses actually change when they go from

mosquito to human and from human to mosquito,
but Zika does this in a more obvious way.”

WHAT’S NEXT?

The faculty members at the core of the

institute’s research team have “self-selected” to

focus on specific kinds of virus infections. But the

relatively small size of the team means ideas easily
cross-pollinate, and discussions in lab meetings or
in the hallway may lead to new questions, answers
and shared expertise. There is no shortage of

known viruses on which to focus so the research

leaders, technicians and students go on working,

networked with the larger scientific community, and
always watching for signs that a new virus may be
emerging, or a well-known one resurging.

Morrey said one frustration is that the

Top: This is a digitally-colorized transmission electron micrograph
(TEM) of Zika virus, which is a member of the family Flaviviridae.
Virus particles, here colored red, are 40 nm in diameter, with an outer
envelope, and an inner dense core. Image courtesy of CDC/ Cynthia
Goldsmith.
Bottom: Human neural progenitor cells (gray) infected with Zika
virus (green) increased the enzyme caspase-3 (red), suggesting
increased cell death. Credit: Sarah C. Ogden, Florida State University,
Tallahassee

procedure for approving new drugs does not

currently work well for fighting emerging diseases.

Regulations require that clinical trials include large
numbers of people. The problem is that cases

of people infected with an emerging disease are

often sporadic and geographically far apart, so it is
extremely difficult or impossible to include enough
people in a single treatment trial.

“It has prevented the development of some

drugs that could be useful, but the FDA is bound

by law,” Morrey said. “The law needs to be adapted
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for emerging diseases like Zika and West Nile virus. It will

require the political will to make those changes. It may require
loosening some standards in order to accomplish the studies,
and no one wants to be blamed for doing something that
might not be safe.” ¤

Contact Info:
John Morrey, John.Morrey@usu.edu
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Genomes

BY DAVID HOLZMAN
& LYNNETTE HARRIS

A

team of researchers at Utah State University has
characterized the consensus genome sequences
of three historically important Zika virus strains,
an important step toward developing antiviral therapeutic and preventive strategies against Zika, and related
viruses. The research is published August 18 in Genome
Announcements, a journal of the American Society for
Microbiology.
“The epidemic in the Americas is potentially

threatening the entire world,” said senior author Young-

Min Lee, associate professor in the College of Agriculture

and Applied Sciences’ Department of Animal, Dairy and
Veterinary Sciences. The new research, he said, may

ultimately lead to stopping Zika’s spread, and preventing
future outbreaks.

Previously, these researchers focused on

understanding the molecular basis of viral replication and
pathogenesis of the Japanese encephalitis virus (JEV), a

mostly neglected but clinically important pathogen, which,

like Zika, is a flavivirus. That research has provided a lot of
information that will be critical to efforts to tame Zika, said
Lee.
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USU scientists successfully sequenced the genomes of three important strains of Zika virus that will be important tools in the search
for treatments and a vaccine against the virus. Back row, left to right: Sang-Im Yun, Jordan Frank, Young-Min Lee, Irina Polejaeva
and Byung-Hak Song. Front row: Chris Davies, Ken White and Justin Julander.

For example, the researchers had sequenced several

clinically important strains of JEV, and had developed a

“reverse genetics” system for manipulating those viruses.
That system made it possible to create recombinant
and mutant JEVs. That, and other tools these

investigators developed for JEV can easily be
adapted to use on Zika.

These tools will allow them to create an

attenuated (less virulent) Zika virus that can
serve as a candidate vaccine, said Lee.
The researchers can attenuate the virus

by inactivating a protein that Zika uses to
invade human cells.

The first of the three Zika virus strains

whose sequences the researchers have

characterized was isolated in 1947, from
a sentinel rhesus monkey in Uganda. “A
sentinel animal is an animal intentionally

placed in a particular environment to detect
the presence of an infectious agent in the

area,” said Lee. “Zika virus was discovered

accidentally in the Zika forest of Uganda during

a search for yellow fever virus, another flavivirus
related to Zika.”

The second strain of Zika was isolated in 1966,
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from a pool of Aedes aegypti mosquitos

in Malaysia. The third strain is responsible
for the epidemic that recently swept Latin

America. It was first isolated in early 2015, in
Puerto Rico, and has now reached Florida,
where it has begun to spread.

From this research, and from an analysis

using the sequences of 29 available Zika

virus genomes, the Utah team has shown

that these viruses fall into two major genetic
lineages: One African and one Asian. The

latter includes both the Malaysian, and the

American epidemic strain. That latter strain is

derived from an ancestor of the Asian lineage.

THINGS
5
EVERYONE NEEDS TO
TOP

KNOW ABOUT

ZIKA
1

Zika primarily spreads through
infected mosquitoes. You can
also get Zika through sex.
Many areas in the United States have the type
of mosquitoes that can spread Zika virus.
These mosquitoes are aggressive daytime biters
and can also bite at night. Also, Zika can be
passed through sex from a person who has Zika
to his or her sex partners.

Meanwhile, questions remain as to

why the strains differentiated. Viruses face
different environments in different hosts,

said Lee. “The most obvious and significant
challenge to the virus is the host immune

response, and evasion of the host immune
response is a key feature of the survival

strategy. Studies are currently underway

2

The best way to prevent Zika is
to prevent mosquito bites.
• Use insect repellent. It works!

at Utah State University to examine the

• Wear long-sleeved shirts and long pants.

on viral replication and pathogenesis.”

• Remove standing water around your home.

Repellent

• Stay in places with air conditioning or
window and door screens.

functional importance of the genetic variation
Other contributors to the genome

sequencing project and co-authors on the

paper are technicians and faculty members
in the College of Agriculture and Applied

Sciences: Sang-Im Yun, Byung-Hak Song,

Jordan Frank, Justin Julander, Irina Polejaeva,

3

Zika is linked to birth defects.
Zika infection during pregnancy can cause a
serious birth defect called microcephaly that is a
sign of incomplete brain development. If you have
a partner who lives in or has traveled to an area
with Zika, do not have sex, or use condoms every
time you have sex during your pregnancy.

Christopher Davies and Kenneth White. ¤

4

Pregnant women should not
travel to areas with Zika.
If you must travel to one of these areas,
talk to your healthcare provider first and
strictly followsteps to prevent mosquito
bites during your trip.

5

Returning travelers infected with
Zika can spread the virus through
mosquito bites.
If you get infected with Zika and a mosquito bites
you, you can pass the virus to the mosquito.
The infected mosquito bites other people, who get
infected. Returning travelers should also use
condoms or not have sex if they are concerned
about passing it to their partners through sex.

Left: Representation of Zika virus. Image courtesy
of Kuhn and Rossmann research groups, Purdue
University.
Above: This photomicrograph revealed some of the
histopathologic changes in this specimen of equine
brain tissue revealing the perivascular inflammation
associated with this West Nile virus (WNV) infection.
CDC/ A. Wilson; Brian W.J. Mahy, BSc, MA, PhD,
ScD, DSc

WWW.CDC.GOV/ ZIKA
CS264222-A

August 2, 2016
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synthesis:
UTAH CLIMATE CENTER HONORED
FOR 125 YEARS OF WEATHER DATA

S

cientists at Utah State University have been recording and reporting daily weather observations for 125
years and the Utah Climate Center was recognized
by the National Weather Service with an Honored Institution
Award for that consistent service and the vast amount of
data it has generated.
Accurate weather forecasts are crucial to decisions that

affect people, corporations, government entities and entire

economies, and those forecasts are built on records of daily

weather observations. Each time Utah Climate Center staffers
gather information about specific details of the day’s weather
they are adding more important data points to an unusually
long record.

“Long records are very important to helping us

understand climate and how things have changed over time,”
said Randy Graham, meteorologist-in-charge at the National

Weather Services’ Salt Lake City office. “Back in the day, this
was about climatology and establishing our climate record.
Now this data is going into numerical weather prediction

By Lynnette Harris

models and helps improve our forecasts.”

Currently, daily observations are made and recorded

by Utah Climate Center employees Martin Schroeder or

Boniface Fasu, and occasionally by center director and State
Climatologist Robert Gillies. Their work is added to records
that include more than 45,600 days-worth of observations.

Fasu explained that each day they record daily maximum and
minimum air temperatures, precipitation, soil temperatures at
four different depths and a description of visibility distances
and note whether it’s sunny, overcast, windy, raining or

snowing. In fact, one of the challenges in documenting the
weather is the weather.

“Reading instruments in a blizzard is really interesting,”

Gillies said. “And once, when a strong inversion had built for
several days, I drove past the entrance to one station twice
because I couldn’t see where to turn off the road.”

Lisa Verzella, a National Weather Service meteorologist

who coordinates the network of Utah’s volunteer observers,

PROFESSOR HONORED FOR IMPROVING LIVES IN AFRICA
By Shelby Ruud & Lynnette Harris

F

or more than 30 years Layne Coppock has led highly successful research programs that also change
peoples’ lives in southern Ethiopia and northern Kenya. His efforts were honored with two prestigious awards,
one for career achievement in eastern Africa from a
professional organization in Ethiopia, and another from the
Board for International Food and Agricultural Development
(BIFAD), recognizing the sustained success of a pastoral
women’s collective-action project initiated in 1999. The
work with the pastoral women was part of the USAID-fund-
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ed Pastoral Risk Management (PARIMA) project at USU
from 1997 to 2009.

Coppock, a professor in the Department of Environment

and Society and a Utah Agricultural Experiment Station
researcher, received the 2015 Scientific Award for

Excellence from BIFAD, is a presidentially appointed board
that advises the United States Agency for International

Development (USAID) concerning links between USAID and
U.S. universities.

The project was novel in that the focus was on a

Science at Utah State

Utah Climate Center Director Robert Gillies with Randy Graham and Lisa Verzella from the National Weather Service’s Salt Lake City office,
and climate center staffers Martin Schroeder and Boniface Fasu (left to right).

said although there are stations with automated sensors,

said. “We often get calls from insurance companies checking

with the instruments they use and how they read them. In

evaluating claims.”

people provide better records because they are familiar
addition, when a severe weather event occurs and road

on weather events on a specific date when they are

Graham said data collected by observers is examined

crews and others need to know about current conditions,

closely after a severe weather event, including information

radar is blocked by mountains.

forecasting tools. Although individuals may think of weather

automated instruments may not “see” the activity because
“But we can contact observers in an area and get a

report of what’s really happening on the ground,” Verzella

from the days and hours preceding it, to help develop better
only in terms of how it affects their plans, forecasting is vital
to the nation’s economy. ¤

participatory, action-research approach

where members of pastoral communities
helped co-direct the work. A blend of

research, outreach, informal education,

and training led thousands of pastoralists—
mostly poor, illiterate women—to empower
themselves and form self-help groups that

saved money, invested wisely in a variety of
economic development activities, improved
risk management in their households

level, and thus helped transform destitute
communities.

“The key to success was building

human, social, and financial capital—not

Collegues Getachew Gabru and Layne Coppock.

the implementation of new production
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Participants in the Pastoral Risk Management project women’s program learned new animal management and business skills that improved
rangeland ecology and their families’ economic well-being.

technology,” Coppock said. “Because the interventions are self-sustaining and easily replicated, the impacts from this project
have grown over time.”

In 2003 there were 2,300 founding members in 59 groups with a savings and loan volume equal to U.S. $650,000. By

2015–6 years after the project formally ended–there are 87,000 participants in 795 groups with a savings and loan volume
over U.S. $28 million.

The work of Coppock and his team of Ethiopian and Kenyan colleagues is the first instance of rangeland-focused work

being recognized by BIFAD. Members of the team include Coppock, Getachew Gebru, Solomon Desta, Seyoum Tezera,
Azeb Yonas, Abdillahi Aboud, Mark Mutinda, and Stellamaris Muthoka.

Coppock was also honored with a career achievement award from the Ethiopian Society of Animal Production. His

career in East Africa has included his role in the National Science Foundation-funded South Turkana Ecosystem Project

(Kenya) in the 1980s, authorship of a book on Ethiopian rangelands in the mid-1990s, stewardship of the PARIMA project,
and his role in Ethiopian land-management research since 2012. After receiving his award, Coppock gave a presentation
concerning interactions in Ethiopian pastoral systems that connect livestock production, human health and water quality.

DeeVon Bailey, associate dean for research in the College of Agriculture and Applied Sciences, who formerly oversaw

international program development at USU, said Coppock is successful because he works with people at the grassroots level
and asks them what they believe would help their situation the most. Then the research, outreach, and training aspects are
packaged around those goals.

“I consider his programs, especially the PARIMA pastoral women’s program, to be the most successful U.S. university-

implemented program I have seen during the almost 20 years I have been working in Africa,” Bailey said. “Layne has

discovered the key that marginalized, uneducated people are trapped by poverty. They are very talented and thus capable

of solving many of their own problems, but they need to be empowered to do so. Empowerment comes from respecting their

wisdom, providing guidance, and helping them gain access to the appropriate tools and techniques. Such success does not
come from top-down research initiatives.”
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EXPERIMENT STATION
GETS NEW ASSOCIATE
DIRECTOR
By KailCee Harrison

C

hris Davies, research associate professor in
the Department of Animal, Dairy and Veterinary Sciences, was recently named associate
director of the Utah Agricultural Experiment Station.
Davies received both his Doctor of Veterinary

Medicine and PhD from Cornell University. Before
joining Utah State University in 2007, he was a

researcher and associate professor at Washington State
University.

Davies’ strong background in animal science

Research Associate Professor Chris Davies.

research and work with USU’s Center for Integrated
BioSysems have prepared him for the new position.
While working on his undergraduate and graduate
degrees he trained horses, worked at the Cornell

Dairy and became interested in immunology, which,

ultimately led to his career in studying immunogenetics.
His research at USU focuses on immune response

and gene expression at the maternal-fetal interface,
specifically in cattle. Davies is excited to use his

research background to further the mission of the Utah
Agricultural Experiment Station.

“Utah State University has a strong agricultural

research program,” Davies said. “We are one of the

top Ag schools in the country and I want to continue to
build on that success. Part of that is overseeing use
of money to strengthen programs and provide core

resources for our faculty who conduct research. Many
people don’t know that although most experiment

station researchers are in the College of Agriculture

and Applied Sciences, we also support projects in the
university’s colleges of science, natural resources,

education and human services, engineering and in
humanities and social sciences.”

Davies is assuming the position formerly held by

long-time UAES Associate Director Donald Snyder who
retired in June. Davies will work to support the Utah

Agricultural Experiment Stations mission of generating

knowledge and new technology to “improve the diverse

For 10 weeks last summer, nine students from small colleges in Utah
and surrounding states worked in research laboratories with USU faculty
mentors in the Summer Undergraduate Agricultural Biotechnology Research
Experience (SURE). “I think the connections and the experiences that come
from this unique program have a lot of potential to change students’ career
objectives and opportunities,” said Chris Davies, the program’s co-director.
Students received a stipend for their work improving crop varieties,
developing biofuels, studying antiviral drugs and exploring other agricultural
and biological problems.

Utah’s citizens.” His primary responsibility will be to

Jackie Bedoya-Wilkinson, a student at Weber State University said, “I never
thought I would be able to participate in undergraduate research. I didn’t
even know how to get started. Now I get to use state-of-the-art equipment
to work on important projects every day.”

U.S. Department of Agriculture to ensure that it is used

Davies said the SURE program is set to continue for at least the next 2
years with funding from the USDA.

system of agriculture and natural resources that feeds,
clothes, houses and enhances the environment for

manage research funding from the State of Utah and
and reported on appropriately. ¤
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T

here is an eye-catching photo of a fat mouse and
a thin mouse on the flyer soliciting participants for
a campus research project. You might conclude
that this study is related to diet and exercise, but it isn’t.
Both mice were fed the same diet; the only variable is
the bacteria in their gut. Korry Hintze, a Utah Agricultural
Experiment Station researcher and associate professor
in Utah State University’s Department of Nutrition, Dietetics and Food Sciences, is studying how this could be
applied to human health.
“Gut bacteria, or microbiome, has co-evolved along

with humans and animals, Hintze said. “Only recently

have we been able to understand many of the ways it
relates to health. The field exploded because of DNA

sequencing. It is an easier and cheaper way to examine
bacteria than the old methods of bacteria culturing, and
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some bacteria could not be cultured. “

There was a time when we thought all bacteria were

harmful and that using antibiotics to kill them would lead
to better health, Hintze said. But there are as many as

1,000 species of microorganisms in the human digestive
tract, and more recently, scientists are discovering how
useful and variable the microbiome is. For instance,

Cesarean-delivered babies have a different microbiome
than those born vaginally. This is because babies are

born pretty much sterile and acquire bacteria from their
mothers at delivery. So babies delivered via C-section

have a microbiome more analogous to their mother’s skin
as opposed to the mother’s natural gut microbiome.
We also now know that breast feeding plays an

important role in both the health of the baby and the

OUR COMPLICATED
RELATIONSHIP
WITH THE
MICROBIOME
By Dennis Hinkamp

microbiome, Hintze said. Breast
milk contains indigestible milk
fiber. Because species don’t
generally develop wasteful
adaptations, researchers

conclude that a large part of

breast milk is not there for the
baby; it’s there for the newly

emerging bacteria in the baby’s
gut.

Microbiome variability is a

proven factor in mouse weight gain.

Counterintuitively, the more efficient the

bacteria, the greater chance of obesity. Is

swapping microbiomes a cure for obesity?
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“It’s well
known that obese mice
have microbiomes that are more
efficient at making this conversion
Mice and humans consume food

that may not be digestible to them

but is digestible to the microbiome,

and returning energy to the host,”

can convert more of that food to

Hintze said. “There are, however,

absorbed as added calories. The less

a lot of unknowns about how this

Hintze said. More efficient gut bacteria
short-chain fatty acids which can be

efficient bacteria let undigested food
pass through as waste.

would work in humans. We are
not as reliant on short chain fatty
acids. Mice have a fermentation

pouch in their digestive system that aids
digestion and we don’t.”

The “Fecal

Microbiota Transplant
Study” is designed to

answer some of these

questions, Hintze said. The
Center for Human Nutrition
Studies will collect fecal

samples from lean and obese
volunteers. The samples will
be homogenized in a saline
solution and transferred to

the mice through a feeding
tube. The mice will then be
fed low and high calorie

diets and monitored to see
if the human microbiome
affects their weight gain.

Their health, weight and body
composition will be examined
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to see if the human microbiome characteristics are
transferred to the mice.

“This used to be an extremely expensive process

because of the difficulty of raising research mice that
were bacteria-free,” Hintze said. “We have found

a quicker, less expensive way of starting the mice

off bacteria free. We treat them with antibiotics for 2

USU’s Center for Human Nutrition Studies. If you search
the Internet you will find tutorials on concocting fecal

transfer home remedies. The danger is that you don’t

know what microbiome traits you might be transferring.

Certain microbiome characteristics are also associated
with diabetes and colon cancer.

Hintze said “probiotics” available as supplements

weeks prior to the transfers.”

are generally regarded as safe, but there isn’t much

but doctors are proceeding with caution, he said.

effective. If they do work, you must consume them

Human to human fecal transplants show promise

Microbiome transplants from healthy humans to those
infected with clostridium difficile colitis “c-diff” have

good research to support the claims that they are

regularly because they don’t survive well in the gut.
Studying the microbiome brings into question

been 98 percent effective at curing the sometimes

exactly what we are. There’s “us” and also the symbiotic

usually in care facilities, who have had long-term

at ourselves as more of a superorganism rather than us

deadly bacterial infection that can develop in people,
antibiotic treatment. Because antibiotics destroy

many of the microorganisms that normally keep c-diff
bacteria in check, it can grow without competition

and release toxins that attack the intestinal lining and
can cause life-threatening holes in the intestines or
inflammation in the colon.

We shouldn’t have to say this, but “don’t try this

at home,” said Janet Bergeson, clinical coordinator at

bacteria that live inside us. Hintze said we need to look

and them. For the health of the superorganism we need

to consider the effects of foods and medicines not just on
us, but also on the microbiome that coexists with us. ¤

Contact Info:
Korry Hintze
Korry.Hintze@usu.edu

Left: Undergraduate researchers Niklas Aardema and Ashli Hunter working with mice in the lab.
Above: Human nutrition researchers Korry Hintze, Daphne Rodriguez and Janet Bergeson.
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S

cientists from Utah State University and the University of Utah have
developed a new animal model to better understand atrial fibrillation, the most common type of heart arrhythmia.

Irena Polejaeva in USU’s College of Agriculture and Applied

Sciences, and Ravi Ranjan, from the U of U School of Medicine, lead a

team of researchers that have created the first transgenic goat model for
atrial fibrillation. Their findings were recently published in the Journal of
Cardiovascular Electrophysiology.

According to Polejaeva, associate professor in USU’s Department

of Animal, Dairy and Veterinary Sciences, there are typically two types of

models used in cardiology: transgenic mouse models commonly used to

understand gene function, and large animal models including pigs, goats
and dogs that are not genetically modified.

“What we’ve done is combine these two approaches,” Polejaeva said.

“We produced a transgenic large animal model, which makes several

conditions much more reproducible because it is similar to a human-sized
heart.”

Now the researchers are studying the relationship between atrial

fibrillation and cardiac fibrosis, the formation of excess fibrous connective
tissue in the heart that lowers its functionality. This condition is commonly
associated with atrial fibrillation, though the exact relationship is unclear.
Polejaeva said with atrial fibrillation affecting upwards of 2.7 million

adults in America and causing an irregular, rapid heartbeat and leading to
fainting, chest pain, stroke, heart failure and other health problems, there
was a need for a more effective way to study these heart conditions.

“This goat model, that closely and uniquely resembles the human

disease, provides a unique platform to study and gain a mechanistic

understanding of how fibrosis makes these hearts more susceptible to atrial
fibrillation,” said Ranjan, doctor and associate professor in the Division of
Cardiovascular Medicine and clinical electro physiologist at the U of U.

According to Ranjan, this model will play a key role in developing new

drugs, examining device-related treatments, and identifying the best timing
and duration of preventative treatments.

The Utah Science Technology and Research Initiative (USTAR), the

Utah Agricultural Experiment Station and the American Heart Association
currently fund the project.

Other researchers involved in the successful collaboration and co-

authors on the report are: Christopher Davies, Misha Regouski, Justin Hall,
Aaron Olsen, Quinggang Meng, Heloisa Rutigliano, Aaron Thomas, Rusty
Stott, Kip Panter Arnaud VanWettere, John Stevens, Zhongde Wang and
Kenneth White at Utah State University; Derek Dosdall, Nathan Angel,

Frank Sachse, Thomas Seidel, Rob Macleod and Nassir Marrouche at the
University of Utah; Pamela Lee, Washington State University College of
Veterinary Medicine.

Contact Info:
Irina Polejaeva, Irina.Polejaeva@usu.edu

Left: USU Associate Professor Irena Polejaeva.
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ONE HEALTH
AND EMERGING
INFECTIOUS
DISEASES
By E. Bart Tarbet, Research Associate Professor
Department of Animal, Dairy and Veterinary Sciences

F

rom 2010 to 2015, Utah State University’s Institute
for Antiviral Research and Center for Integrated
BioSystems trained personnel from vaccine manufacturers in developing countries in support of the World
Health Organization’s international vaccine production
capacity building program. Through that involvement I
became interested in global public health, and teaching
microbiology and infectious diseases in the new School
of Veterinary Medicine has expanded my interest to
global animal health. I have heard it said that we are all
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part of a “global village”. In our modern world infectious
diseases can travel remarkably fast.
Over the last 30 years, approximately 75% of new

and emerging human diseases have been zoonotic

(meaning a disease transmitted from animals to people),

and many have come from wildlife.1 The Foresight Report

describes the projected risks from infectious diseases
of humans, animals and plants over 10- and 25-year
horizons, and predicts that the highest probability of

emergence will be associated with RNA viruses, especially those found at the
human-animal interface.2 Understanding the mechanisms that underlie newly

emerging and reemerging infectious diseases is one of the most difficult scientific
problems facing society today. Examples of human disease outbreaks that had
their initial transmission from animals include: avian influenza in 1997, Severe

Acute Respiratory Syndrome (SARS) in 2003, the novel swine-origin H1N1 strain of
influenza A virus in 2009, and Middle East respiratory syndrome (MERS) in 2012.
It is critical for the future control of disease outbreaks to understand and

respond appropriately to new and emerging disease threats. This will require
a paradigm shift from outbreak response, to predicting the outbreak before it

happens. One such approach involves One Health, the emerging discipline that
brings together human, animal and environmental health. The first Utah One

Health Symposium was held in October 2015, and members of the USU School
of Veterinary Medicine played an important role in the success of that event.

Another symposium on this new and important topic is set for October 2016.
The essence of One Health is a collaborative, integrated, and

multidisciplinary approach to better understand and better address the

challenges and threats of infectious diseases to humans and animals. This
approach will require infectious disease experts, physicians, veterinarians
and environmental scientists to collaborate and identify the underlying

drivers of disease emergence and develop interventions that prevent the

transmission of disease. We need to understand the conditions that allow

diseases to emerge and spread due to increased population density in cities,
increased use of intensive farming practices, and increased travel globally.

In addition, we must learn from recent experiences, and move from a crisis-

Research Associate Professor Bart Tarbet.

driven society to one of prevention and preparedness.

One Health as a concept embraces disease ecology, and contributes to a better understanding of emerging

disease dynamics and the interdependence between human, animal and environmental health in addressing

emerging disease threats. ¤

___________________________

Bart Tarbet began his training in infectious diseases (medical microbiology) at the Louisiana State University Medical

Center in 1992. He worked for 12 years in the vaccine industry and developed veterinary vaccines to emerging (West

Nile Virus) and reemerging (influenza virus) diseases in multiple species of animals. At the USU Institute for Antiviral

Research, his research in human and animal infectious diseases has merged into developing animal models of human
infectious disease for evaluation of experimental therapeutics and vaccines.
References
1 Taylor, L.H., Latham, S.M., Woolhouse, M.E. (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci.
356:983-9.
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